<p>Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets</p>-Reference-Cited by-同舟云学术

Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets

Published:2020-05 Issue: Volume:Volume 14 Page:1953-1961
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Hwang Jungi,Yu Kyung-Sang,Lee SeungHwan

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference19 articles.

1. Blood Pressure and Cholesterol Control in Hypertensive Hypercholesterolemic Patients

2. Hypercholesterolemia and Hypertension: Two Sides of the Same Coin

3. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

4. Cardiovascular Disease Risk Factors: Epidemiology and Risk Assessment

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants;Advances in Therapy;2024-05-21

2. Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions;2024-04-09

3. A Fully Replicate, Cross-over, Bioequivalence Study to Compare Two Prolonged Release, Multi-matrix Tablet Formulations of Budesonide in Healthy Indian Adults;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2023

4. Co-Administration of Vonoprazan, Not Tegoprazan, Affects the Pharmacokinetics of Atorvastatin in Healthy Male Subjects;Frontiers in Pharmacology;2021-11-11

5. A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy;Pharmacology Research & Perspectives;2021-09-03